A 32-year-old woman with confirmed PCOD presents with secondary infertility for 3 years. Baseline hormonal workup shows normal prolactin and TSH. Transvaginal ultrasound confirms polycystic ovaries. She has been on metformin for 6 months without ovulation. What is the most appropriate next investigation to assess ovulatory status before proceeding to ovulation induction?

## Assessment of Ovulatory Status in PCOD-Related Infertility **Key Point:** Serum progesterone on day 21 of the menstrual cycle is the gold standard functional test to confirm ovulation and assess luteal phase adequacy before proceeding to ovulation induction therapy. ### Why Day-21 Progesterone? Progesterone is produced by the **corpus luteum** after ovulation. A mid-luteal phase (day 21 in a 28-day cycle, or 7 days before expected menses) progesterone level: - **Confirms ovulation** if level >3 ng/mL (>10 nmol/L) - **Assesses luteal phase adequacy** if level >10 ng/mL (>32 nmol/L) - Is the **functional marker** of ovulation, not just morphologic ### Interpretation of Day-21 Progesterone | Progesterone Level | Interpretation | Action | |-------------------|----------------|--------| | **<3 ng/mL** | No ovulation | Continue/escalate ovulation induction | | **3–10 ng/mL** | Borderline/weak ovulation | May need luteal support or higher induction dose | | **>10 ng/mL** | Adequate ovulation & luteal phase | Proceed to timed intercourse or IUI | **High-Yield:** In PCOD with anovulation despite metformin, progesterone testing confirms whether the patient is responding to current therapy or requires escalation (clomiphene citrate, gonadotropins, or letrozole). ### Why Other Options Are Incorrect **Serum estradiol on day 3:** - Measures **basal follicular phase** estradiol (ovarian reserve marker) - Does NOT assess ovulation or luteal function - Used for ovarian reserve assessment, not ovulatory confirmation **Hysterosalpingography:** - Assesses **tubal patency and uterine cavity** morphology - Important in infertility workup but does NOT assess ovulation - Indicated after confirming ovulation to rule out tubal factor **Diagnostic laparoscopy with ovarian biopsy:** - Invasive procedure with morbidity - Not indicated for simple ovulatory assessment - Reserved for suspected endometriosis, adhesions, or when diagnosis is unclear **Clinical Pearl:** Always obtain day-21 progesterone **before** escalating to gonadotropins or IUI in PCOD-related anovulation. It is non-invasive, inexpensive, and provides definitive functional evidence of ovulation. **Mnemonic: OPT** — **O**vulation confirmed by **P**rogesterone on day **T**wenty-one. [cite:Park 26e Ch 12; Harrison 21e Ch 297]